Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

These RCT findings support safety and efficacy in 6 to 12 year olds, but there are many unanswered questions, one expert says ...

By week 56, kids, ages 6 to <12 years, on once-daily 3-mg liraglutide lost 5.8% of BMI compared with a 1.6% gain with ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the ...

Liraglutide plus lifestyle intervention is efficacious for children aged 6 to <12 years with obesity, according to a study ...

Liraglutide has been found to safely reduce BMI in children aged 6 to under 12, offering a potential new treatment for pediatric obesity. The obesity medication liraglutide was found to be safe and ...

The weight-loss drug liraglutide (Saxenda) helped obese children lower their BMI and reach a healthier weight, researchers ...

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication ...